Internal Reference Number: FOI_6513
Date Request Received: 14/03/2022 00:00:00
Date Request Replied To: 11/04/2022 00:00:00
This response was sent via: By Email
Request Summary: Diagnosis and treatment of immune thrombocytopenia.
Request Category: Companies
| Question Number 1: In the last 6 months, how many patients has your trust treated (for any condition) with the following treatments 鈥� Avatrombopag 鈥� Eltrombopag 鈥� Fostamatinib 鈥� Romiplostim | |
| Answer To Question 1: Eltrombopag 7 Fostamatinib 0 Romiplostim 8 Avatrombopag 0 | |
| Question Number 2: In the last 6 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3)? | |
| Answer To Question 2: Less than 5 patients have been treated for Immune thrombocytopenia | |
| Question Number 3: In the last 6 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3) ONLY with the following treatments: 鈥� Avatrombopag 鈥� Mycophenolate mofetil 鈥� Rituximab 鈥� Surgery (splenectomy) | |
| Answer To Question 3: This information is not recorded, unable to answer. | |
| Question Number 4: Does your trust participate in any clinical trials for the treatment of Immune thrombocytopenia? If so, can you please provide the name of each trial and the number of patients taking part. | |
| Answer To Question 4: Currently no such trials are taking place | |
| To return to the list of all the FOI requests please click here |
Our staff at 黑料网 District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
